Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Cash flow is valuable, but it’s not everything - StockStory helps you identify the companies that truly put it to work. That said, here are three cash-producing companies that don’t make the cut and some better opportunities instead.
MGM Resorts (MGM)
Trailing 12-Month Free Cash Flow Margin: 8.4%
Operating several properties on the Las Vegas Strip, MGM Resorts (NYSE:MGM) is a global hospitality and entertainment company known for its resorts and casinos.
Why Do We Steer Clear of MGM?
- The company has faced growth challenges as its 2% annual revenue increases over the last two years fell short of other consumer discretionary companies
- Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results
MGM Resorts is trading at $43.75 per share, or 24.7x forward P/E. Dive into our free research report to see why there are better opportunities than MGM.
Inspire Medical Systems (INSP)
Trailing 12-Month Free Cash Flow Margin: 13%
Offering an alternative for the millions who struggle with traditional CPAP machines, Inspire Medical Systems (NYSE:INSP) develops and sells an implantable neurostimulation device that treats obstructive sleep apnea by stimulating nerves to keep airways open during sleep.
Why Are We Cautious About INSP?
- Subscale operations are evident in its revenue base of $898.7 million, meaning it has fewer distribution channels than its larger rivals
- Forecasted revenue decline of 3.5% for the upcoming 12 months implies demand will fall off a cliff
Inspire Medical Systems’s stock price of $61.46 implies a valuation ratio of 46x forward P/E. If you’re considering INSP for your portfolio, see our FREE research report to learn more.
CVS Health (CVS)
Trailing 12-Month Free Cash Flow Margin: 2.8%
With over 9,000 retail pharmacy locations serving as neighborhood health destinations across America, CVS Health (NYSE:CVS) operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance through its Aetna subsidiary.
Why Does CVS Give Us Pause?
- Large revenue base makes it harder to increase sales quickly, and its annual revenue growth of 6.9% over the last two years was below our standards for the healthcare sector
- Estimated sales growth of 1.8% for the next 12 months implies demand will slow from its two-year trend
- Incremental sales over the last five years were less profitable as its 1.1% annual earnings per share growth lagged its revenue gains
At $93.94 per share, CVS Health trades at 11.4x forward P/E. Read our free research report to see why you should think twice about including CVS in your portfolio.
Stocks We Like More
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.